AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06349538 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical examination, blood draw, cerebral MRI, sonography, tremor analysis, OCT, olfactory mucosa swab.
Description: see previous descriptions
Study NCT05812781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VTX2735
Description: Dose A
Study NCT05812781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VTX2735
Description: Dose B
Study NCT05868564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Atherectomy+Drug-coated balloon
Description: Patients in experimental group will undergo endovascular treatment for femoropopliteal lesions. The lesion will be treated by atherectomy+drug-coated balloon in the experimental group
Study NCT05868564 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Drug-coated balloon
Description: drug-coated balloon only in the active comparator group.
Study NCT05087524 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: BinaxNOW Ag Card
Description: A nasal swab specimen is collected from the participant, 6 drops of extraction reagent from a dropper bottle are added to the top hole of the swab well. The participant sample is inserted into the test card through the bottom hole of the swab well, and firmly pushed upwards until the swab tip is visible through the top hole. The swab is rotated 3 times clockwise and the card is closed, bringing the extracted sample into contact with the test strip. Test results are interpreted visually at 15 minutes based on the presence or absence of visually detectable pink/purple colored lines.
Study NCT06334445 — intervention group
Intervention type: BEHAVIORAL
Intervention: Control group
Description: Wearables/sensors and ePsycHeart App
Study NCT06334445 — intervention group
Intervention type: BEHAVIORAL
Intervention: Intervention group
Description: Wearables/sensors and ePsycHeart App and eHealtHeart
Study NCT06405009 — intervention group
Intervention type: OTHER
Intervention: Without any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors
Description: Without any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors
Study NCT05445310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Furmonertinib 80mg/d
Study NCT05731674 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Random selection of excercises
Description: Participants in the intervention group will train using a random selection of excercises and complete the profiency-based traning program.
Study NCT05326841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Description: cholecalciferol tablet, the dose is 5000 international unit /day for 12 weeks
Study NCT05326841 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin D3
Description: cholecalciferol tablet, the dose is 5000 international unit /day for 12 weeks
Study NCT05404386 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Training booklet prepared by the researchers on healthy lifestyle behaviors, bladder training, and Kegel exercises related to urinary incontinence.
Description: After the participants enrolled in the study, a training booklet prepared by the researchers on healthy lifestyle behaviors, bladder training, and Kegel exercises related to urinary incontinence will be given to the participants.
Study NCT05404386 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 3 months follow-up
Description: Follow-ups will be made 3 times in total, on the basis of pre-test (baseline), intermediate follow-up test (6th week), and post-test (12th week).
Study NCT05404386 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3 months follow-up
Description: Follow-ups will be made 3 times in total, on the basis of pre-test (baseline), intermediate follow-up test (6th week), and post-test (12th week).
Study NCT05404386 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile application which named as My Fighting with Incontinence
Description: The mobile application My Fighting with Incontinence aims to reduce incontinence symptoms of women with UI, ensure compliance with Kegel exercises, increase health belief and quality of life regarding UI and kegel exercises, and also allow researchers to be included in the awareness and management process.
Study NCT05707962 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Description: All babies with moderate or severe Hypoxic Ischemic Encephalopathy fulfilling the inclusion criteria will be randomized to receive either the standard treatment (oxygen and fluid therapy along with anticonvulsants if required) plus 3.0 ml/kg of 10% dextrose water given over 30 minutes, three dose given 24 hours apart or to receive standard treatment PLUS three doses of Magnesium Sulphate infusion given over 30 minutes at 250 mg/kg per dose given 24 hours apart. The volume of infusion shall be adjusted with 10% dextrose water to make it~up to 3.0 ml. The resulting reconstituted solution for intravenous infusion shall be 8.3% Magnesium Sulphate delivered over 30 minutes at a rate of 0.1 ml/kg/minute i.e. 8.3 mg/kg/minute. The treatment should be started as soon after birth as possible and not later than 24 hours of life. The babies who meet the exclusion criteria will not be continued into the study.
Study NCT03509545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF Patients: ER Torsemide 40 mg
Description: ER Torsemide 40mg given once daily to CHF patients
Study NCT03509545 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CHF Patients: Furosemide 40 mg
Description: Stable CHF patients taking twice-daily 40 mg Furosemide
Study NCT04891744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Selinexor (ATG-010# is a first-in-class, oral selective exportin 1 (XPO1) inhibitor (1,2). Selinexor functions by binding with and inhibiting the nuclear export protein XPO1 (also called CRM1), leading to the accumulation of tumor suppressor proteins in the cell nucleus along with inhibition of translation of oncoprotein mRNAs.
Study NCT04891744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thalidomide
Description: 100mg/d, Po. on day1-28
Study NCT04891744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 20 mg/d Po. on day 1, 2,8,9,15,16,22,23
Study NCT05478395 — intervention group
Intervention type: OTHER
Intervention: Questionnaires set
Description: Participants will be asked to respond to the demographic information，the Depression Anxiety Stress Scale（DASS-21）and the Internet Addiction Test（IAT）.
Study NCT05528744 — intervention group
Intervention type: OTHER
Intervention: Observational Study
Description: No intervention. This is an observational study
Study NCT05528744 — intervention group
Intervention type: OTHER
Intervention: Sample collection only
Description: Collection of blood and/or skin samples.
Study NCT06079229 — intervention group
Intervention type: OTHER
Intervention: Phone call
Description: The only follow-up visit provided for in the protocol was a telephone contact 3 to 30 months after the patient's surgery. The rest of the data required for the study were obtained from the patient's medical records, collected in the course of routine practice.
Study NCT06233747 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Improving Care, Accelerating Recovery & Education (ICARE)
Description: I-CARE is a brief, digital intervention designed for adolescents who are boarding in a medical hospital awaiting transfer to a psychiatric inpatient unit. It consists of 7 tablet-based animated video modules and workbook exercises, facilitated by licensed nursing assistants or other non-specialist clinicians who provide one-on-one safety supervision during boarding. All modules are grounded in evidence-based practices, such as cognitive-behavioral therapy and dialectical behavior therapy. Given that one-on-one safety supervision is the current standard of care during boarding, I-CARE requires minimal additional resources beyond those already available in acute care hospitals and builds on well established research demonstrating the effectiveness of task-sharing, the redistribution of tasks within the workforce, to address the shortage of mental health professionals.
Study NCT06173115 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Perclose Proglide system
Description: Preclosure technique has emerged as a common vascular closure approach using a Perclose Proglide system (Abbott Vascular), in which sutures are deployed before dilating the arterial access site.
Study NCT06173115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Perclose Proglide system
Description: Preclosure technique has emerged as a common vascular closure approach using a Perclose Proglide system (Abbott Vascular), in which sutures are deployed before dilating the arterial access site.
Study NCT05054348 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IO-108
Description: IO-108 given as monotherapy
Study NCT05054348 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IO-108 + pembrolizumab combination therapy
Description: IO-108 and fixed dose pembrolizumab combination therapy
Study NCT05054348 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IO-108 + cemiplimab combination therapy
Description: IO-108 and fixed dose cemiplimab combination therapy
Study NCT04633590 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based exergaming
Description: Participants will undertake one of two 6-week training interventions. In both groups participants will be asked to train 3 times per week (18 sessions total), during which adherence to the training will be measured. To monitor adherence to training and training load (exercise completion, exercise duration and heart rate achieved during workouts) throughout the 6 weeks participants will be given a heart rate monitor.
Study NCT05025215 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Precise Aerosol Inhalation Nursing Program
Description: The precise aerosol inhalation nursing program was based on the traditional oxygen aerosol inhalation treatment, including precise body position care, time control, observation and treatment, evaluation, etc.
Study NCT05025215 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Aerosol Inhalation Nursing Method
Description: The traditional aerosol inhalation nursing method is carried out according to the operation of aerosol inhalation.
Study NCT06657521 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: osteoimplant
Description: Osteoimplant Complex© on the following schedule: 2 tablets per day starting 5 days before implant placement and 1 tablet per day of Osteimplant© for 2 months after implant placement.
Study NCT06657521 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: 2 tablets per day starting 5 days before implant placement and 1 tablet per day for 2 months after implant placement.
Study NCT05454111 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multiscale entropy-guided ablation plus PVI
Description: The multiscale entropy is calculated based on intracardiac electrical signals, higher multiscale entropy value indicates closer to the core of rotors which maintains the persistent atrial fibrillation.
Study NCT05454111 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CARTO-Finder-guided ablation plus PVI
Description: CARTO-Finder-guided ablation plus PVI
Study NCT05005494 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium sulfate IV
Description: Infusion of magnesium sulphate 50 mg/kg (eq. 0.5ml/kg of magnesium sulphate 100mg/ml)
Study NCT05005494 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Infusion of NaCl (sodium chloride) 0.9% (placebo eq. 0.5ml/kg of NaCl 0.9%)
Study NCT03994029 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Effect of polyphenols on hepatic steatosis and vascular elastography and intima media thickness
Description: Measurement of effect of polyphenol supplementation vs placebo on hepatic steatosis and vascular elastography and intima media thickness
Study NCT03994029 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Effect of polyphenols on hepatic steatosis and vascular elastography and intima media thickness
Description: Measurement of effect of polyphenol supplementation vs placebo on hepatic steatosis and vascular elastography and intima media thickness
Study NCT04955678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium, hydrolysed divinylbenzene-Me 2-fluoro-2-propenoate-1, 7-octadiene polymer sorbitol complexes
Description: ZG-801 is powder for suspension. In Run-in period, ZG-801 is taken once a day for 4 or 5 weeks. In Double-blind period, ZG-801 is taken once a day for 4 weeks.
Study NCT04955678 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is powder for suspension. In Double-blind period, Placebo is taken once a day for 4 weeks.
Study NCT06093074 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-management program after traumatic injuries
Description: The self-management support (SMS) program is manualized and will include eight weekly 2.5-hour sessions in groups of 5-7 participants. This feasibility trial will assess both face-to-face delivered program and a tele-health program via electronic devices. The tele-health intervention will be delivered with the same SMS content, frequency, and in-group mode.
Study NCT06103747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
Description: Pharmacokinetic comparison after administration of test drug
Study NCT06103747 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
Description: Pharmacokinetic comparison after administration of test drug
Study NCT06103747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Galvumet® Film Coated Tablets (850 mg / 50 mg)
Description: Pharmacokinetic comparison after administration of reference drug
Study NCT06103747 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Galvumet® Film Coated Tablets (850 mg / 50 mg)
Description: Pharmacokinetic comparison after administration of reference drug
Study NCT06265142 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Bladder catheterization
Description: Participant will undergo the standard bladder catheterization for urine collection
Study NCT06265142 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: clean catch urine via bladder massage technique
Description: Participant will undergo clean catch urine via bladder massage technique
Study NCT06184347 — intervention group
Intervention type: OTHER
Intervention: Rapid tests for HBsAg
Description: Participants in the screening group will firstly receive the HBsAg screening using a finger blood test.~The laboratory examination includes blood routine test (white blood cell count \[WBC\], red blood cell count \[RBC\], hemoglobin \[HGB\], platelet count \[PLT\]), liver function (total bilirubin \[TBIL\], albumin \[ALB\], alanine aminotransferase \[ALT\]), HBV serologic markers, alpha-fetoprotein(AFP) , abnormal Prothrombin II (PIVKA II) and HBV-DNA.~The imaging examination includes liver ultrasound, abdominal CT, or MRI. HBsAg-positive participants also undergo liver ultrasound examination. If suspicious liver nodules or elevated AFP levels are detected, further refinement through abdominal CT or MRI is recommended.
Study NCT04897490 — intervention group
Intervention type: OTHER
Intervention: Evaluation of first line treatment with ATO/ATRA outcome
Description: Evaluation of first line treatment with ATO/ATRA outcome (o event free survival and overall survival and toxicity) in adult patients with APL.
Study NCT05718245 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HEPA filter
Description: HEPA filters with the capacity to reduce PM2.5 levels
Study NCT05718245 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: HEPA filter
Description: HEPA filters with the capacity to reduce PM2.5 levels
Study NCT01133145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: knee joint transplantation
Description: transplantation of a kne joint from a multi organ donor to a recipient with a severly injured knee joint
Study NCT06224114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Coloured-light torch
Description: Participant administered, at-home, 3-minute daily morning application (between 8 - 10am) of a coloured-light torch to the study eye.
Study NCT06224114 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Different coloured-light torch
Description: Participant administered, at-home, 3-minute daily morning application (between 8 - 10am) of a different coloured-light torch to the study eye.
Study NCT05486403 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Appetite Toolbox Programme
Description: Preschool educators are trained to deliver a bio-behavioural classroom-based programme focusing on building skills in i) appetite awareness, ii) attention/attention control and iii) sensing body cues. The programme is delivered using a combination of interactive story books, classroom props and activities, and mealtime transitions/routines.
Study NCT05486403 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Appetite Toolbox Programme
Description: Preschool educators are trained to deliver a bio-behavioural classroom-based programme focusing on building skills in i) appetite awareness, ii) attention/attention control and iii) sensing body cues. The programme is delivered using a combination of interactive story books, classroom props and activities, and mealtime transitions/routines.
Study NCT05855304 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual therapy
Description: The leg length was measured while the subjects were lying on their stomachs. Then, by grasping the lateral malleolus, the knees are bent 90 degrees and changes in leg length were observed, the positions of the SI joints were noted. Afterwards, the person
Study NCT05855304 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiology taping
Description: As part of the tape (kinesio tex brand) kinesio protocol used in this study, the starting position of the kinesio tape is the site of lumbar spine flexion. Kinesio tape was applied transversely to the bilateral sacroiliac joint area as a long I-shaped piece of tape with 80% tension and no tension was applied to the ends of the tape. Another short tape will be adhered to the SI joint with 80% tension at a right angle to the hip, and no tension is applied to the ends of the tape.
Study NCT05718245 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham filter
Description: sham filters without the capacity to reduce PM2.5 levels
Study NCT05718245 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham filter
Description: sham filters without the capacity to reduce PM2.5 levels
Study NCT04990180 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shared Decision Making Intervention
Description: Decision coaching will be provided to the Pulmonary Rehabilitation Specialists to provide the skills needed to facilitate shared decision making between themselves and patients (and carers). The patient decision aid will be an informational booklet which describes the available Pulmonary Rehabilitation options at the University Hospitals of Leicester. It will detail the risks and benefits of each option and provide interactive sections to engage patients with the content, guide them through it, encourage them to attribute personal meaning and preference to each one so they can make an informed and values-based decision about PR.
Study NCT06081088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graded Motor Imagery (GMI) training
Description: GMI consists of three basic components:~1. Left / Right Discrimination training (Lateralization training): For lateralization training, patients will be trained by asking them to distinguish between right and left with images taken at various angles and positions in the RecogniseTM (NOI-Australia) applications (shoulder and hand sections) (In weeks 1 and 2).~2. Motor Imagery (Explicit Motor Imagery): At this stage, the participant will be asked to imagine doing various functional activities (brushing teeth, combing hair, etc.) in the position they feel most comfortable in and in a quiet environment (In weeks 2 and 3).~3. Mirror Therapy (providing visual feedback through a mirror): In this phase, active ROM exercises and progressive resistance exercises with simultaneous movement of the affected and unaffected extremities will be applied using a standard size posture mirror (In weeks 3-6).~This program will be applied for 6 weeks (3 sessions per week).
Study NCT06081088 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy
Description: Conventional physiotherapy program includes passive, active-assistive (wand exercises) and active ROM exercises for shoulder joint, passive / active posterior and anterior capsule stretching exercises, superior-inferior, mediolateral and distraction techniques for scapular mobilization exercises, shoulder flexion, abduction, internal and external rotation muscles strengthening exercises, static and dynamic stabilization exercises for proprioception exercises. To reduce the pain that may occur after exercises, cold application and Transcutaneous Electrical Nerve Stimulation (TENS) will be applied to benefit from their analgesic effects. Cold application will be applied around the shoulder using a coldpack (gel pack) cold therapy for 15 minutes. Conventional TENS application around shoulder will be performed using a TENS device and four separate 2 × 2 inch self-adhesive electrodes for 15 minutes.This program will be applied for 6 weeks (3 sessions per week).